CWM
SLNO

CIBC World Markets’s Soleno Therapeutics SLNO Stock Holding History

CIBC World Markets’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$415K Sell
4,951
-726
-13% -$54.3K ﹤0.01% 949
2025
Q1 		$406K Buy
+5,677
New +$276K ﹤0.01% 1107

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CIBC World Markets's SLNO Position: Q2 2025 in Review

CIBC World Markets reduced its Soleno Therapeutics (SLNO) stake by 13% in Q2 2025, selling an estimated $54.3K and leaving 4,951 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

CIBC World Markets first reported a position in SLNO in Q1 2025 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold SLNO as of Q2 2025.

  • CIBC World Markets held 4,951 shares of Soleno Therapeutics worth $415K as of Q2 2025.
  • CIBC World Markets sold 726 Soleno Therapeutics shares in Q2 2025, an estimated $54.3K.
  • Soleno Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #949 holding.
  • CIBC World Markets first reported a position in Soleno Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.